All spheres of the world economy are constantly changing. The main reasons are competition, progress in science, new technologies, customer requirements solve a key role in development. Every year in any sphere all above requirements are imposed and the sphere of healthcare not an exception.
Health systems often need to reimburse patients for expensive drugs and treatment because of limited client resources. The choice of drugs is quite a difficult task because of the opaque pricing. Modern approaches to pricing education have the opportunity to address the challenges faced by the health sector in assessing the financing of new drugs, so that the chosen solution satisfies the decision of equity of invested funds and the resulting effect.
Today, health systems around the world do not have the necessary infrastructure to monitor and implement innovative pricing models, such as the formation of the price of drugs on the basis of benefit. The medical complex is not very willing to accept such innovations. Because of this problem, many institutions are forced to refuse treatment to patients who need it most.
The lack of real data on the results of applied medical drugs plays a key role in decision-making health and has the most valuable for effective treatment.
However, the method of collecting real data is not implemented due to delays in obtaining this information, the high cost of obtaining information. It is obvious that the use of real data has many advantages.
The lack of easy and cheap access to good data does not allow stakeholders to evaluate the implementation of this approach for the effectiveness and value for patients.
The most important thing is that the existing shortcomings of the current global health infrastructure lead to inefficiency of the whole system, deterioration of the patient's health as the main participant in the process. Unfortunately, today the health care system is not aimed at mutually beneficial cooperation of medical institutions and suppliers, as well as improving the health of patients.
To solve the existing problems is the goal of the project Digipharm! I really want to tell you about it!
The project aims to revolutionize the provision of health services! Its main feature is the service of patients on the basis of value for them. This solution eliminates existing barriers and automates the introduction of an innovative approach using an independent platform. The platform also provides individual reimbursement of treatment costs based on results. This concept is beneficial to patients, suppliers and manufacturers. Digipharm is the world's first live platform that provides real-world data for health-related research and it encourages patients to enter their data into it.
So, what solutions does Digipharm offer?
The platform consists of two components of Reimburse and Insights. Each component has its own functions.
The reimburse platform takes advantage of smart contracts and blockchain technology. It allows to see dynamic data in real time enables rapid implementation of truly innovative solutions for efficient pricing that will meet the medical companies and manufacturers reducing the time to deploy. Calling platform accelerates integration and shorten delivery time of medical services, improve patient treatment outcomes and accelerate time to pay.
Insights platform will provide anonymous patient data from Reimburse platform and thus ensure the creation of the world's first live and reliable database. The development of such a database will allow the introduction of knowledge into the delivery system in real time and facilitate decision-making for the development of new drugs. And patients will be motivated to bring real data into the system to gain access to low prices.
In my opinion, the project will be in demand all over the world, as it optimizes the healthcare industry and revolutionizes. It completely changes priorities and puts the main thing in system of the patient. Also, the project is humanistic in nature.
At the moment, the project is raising funds for the development of this revolutionary platform.
I suggest to get acquainted with the project on the links in more detail:
Website: https://www.digipharm.ch/
Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf
Telegram group: https://t.me/digipharm
My bitcointalk profile: https://bitcointalk.org/index.php?action=profile;u=1187301